Literature DB >> 21124213

Clinical spectrum and molecular pathophysiology of Shwachman-Diamond syndrome.

James N Huang1, Akiko Shimamura.   

Abstract

PURPOSE OF REVIEW: Shwachman-Diamond syndrome (SDS) is an inherited bone marrow failure and cancer predisposition syndrome that affects multiple organ systems. Mutations in the Shwachman-Bodian-Diamond syndrome (SBDS) gene are found in the majority of patients, but the molecular function of the SBDS protein product remains unclear. In this article, we review recent progress in the clinical and molecular characterization of SDS. RECENT
FINDINGS: Emerging data support a multifunctional role for the SBDS protein. Current studies indicate that SBDS functions in 60S large ribosomal subunit maturation and in mitotic spindle stabilization. Recent data suggest that it may also affect actin polymerization, vacuolar pH regulation, and DNA metabolism. SBDS loss results in both hematopoietic cell-intrinsic defects as well as marrow stromal abnormalities.
SUMMARY: SDS is a multisystemic disease arising from defects in a protein that participates in several essential cellular processes. Elucidating the molecular function of SBDS will provide important insights into how defects in ribosome biogenesis and mitotic spindle stabilization result in hematopoietic failure, cancer predisposition, and abnormalities.

Entities:  

Mesh:

Year:  2011        PMID: 21124213      PMCID: PMC3485416          DOI: 10.1097/MOH.0b013e32834114a5

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  44 in total

1.  Lentiviral-mediated RNAi inhibition of Sbds in murine hematopoietic progenitors impairs their hematopoietic potential.

Authors:  Amy S Rawls; Alyssa D Gregory; Jill R Woloszynek; Fulu Liu; Daniel C Link
Journal:  Blood       Date:  2007-07-17       Impact factor: 22.113

2.  Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome.

Authors:  Barbara Crescenzi; Roberta La Starza; Constantina Sambani; Agapi Parcharidou; Valentina Pierini; Valeria Nofrini; Lucia Brandimarte; Caterina Matteucci; Franco Aversa; Massimo Fabrizio Martelli; Cristina Mecucci
Journal:  Br J Haematol       Date:  2008-11-11       Impact factor: 6.998

3.  The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA.

Authors:  Karthik A Ganapathi; Karyn M Austin; Chung-Sheng Lee; Anusha Dias; Maggie M Malsch; Robin Reed; Akiko Shimamura
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

4.  Shwachman-Diamond syndrome neutrophils have altered chemoattractant-induced F-actin polymerization and polarization characteristics.

Authors:  Claudia Orelio; Taco W Kuijpers
Journal:  Haematologica       Date:  2009-02-11       Impact factor: 9.941

Review 5.  Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment.

Authors:  Lauri Burroughs; Ann Woolfrey; Akiko Shimamura
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

6.  The route to development of myelodysplastic syndrome/acute myeloid leukaemia in Shwachman-Diamond syndrome: the role of ageing, karyotype instability, and acquired chromosome anomalies.

Authors:  Emanuela Maserati; Barbara Pressato; Roberto Valli; Antonella Minelli; Laura Sainati; Francesco Patitucci; Cristina Marletta; Angela Mastronuzzi; Furio Poli; Francesco Lo Curto; Franco Locatelli; Cesare Danesino; Francesco Pasquali
Journal:  Br J Haematol       Date:  2009-02-17       Impact factor: 6.998

Review 7.  Shwachman-Diamond syndrome: implications for understanding the molecular basis of leukaemia.

Authors:  Yigal Dror
Journal:  Expert Rev Mol Med       Date:  2008-12-23       Impact factor: 5.600

8.  Depletion of the Shwachman-Diamond syndrome gene product, SBDS, leads to growth inhibition and increased expression of OPG and VEGF-A.

Authors:  Abdallah Nihrane; Gulay Sezgin; Sehba Dsilva; Paul Dellorusso; Kazuhiko Yamamoto; Steven R Ellis; Johnson M Liu
Journal:  Blood Cells Mol Dis       Date:  2008-11-17       Impact factor: 3.039

9.  Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome.

Authors:  Karyn M Austin; Mohan L Gupta; Scott A Coats; Asmin Tulpule; Gustavo Mostoslavsky; Alejandro B Balazs; Richard C Mulligan; George Daley; David Pellman; Akiko Shimamura
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

10.  The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast.

Authors:  Tobias F Menne; Beatriz Goyenechea; Nuria Sánchez-Puig; Chi C Wong; Louise M Tonkin; Philip J Ancliff; Renée L Brost; Michael Costanzo; Charles Boone; Alan J Warren
Journal:  Nat Genet       Date:  2007-03-11       Impact factor: 38.330

View more
  17 in total

1.  Deficiency of the ribosome biogenesis gene Sbds in hematopoietic stem and progenitor cells causes neutropenia in mice by attenuating lineage progression in myelocytes.

Authors:  Noemi A Zambetti; Eric M J Bindels; Paulina M H Van Strien; Marijke G Valkhof; Maria N Adisty; Remco M Hoogenboezem; Mathijs A Sanders; Johanna M Rommens; Ivo P Touw; Marc H G P Raaijmakers
Journal:  Haematologica       Date:  2015-07-16       Impact factor: 9.941

2.  MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction.

Authors:  Jad I Belle; HanChen Wang; Amanda Fiore; Jessica C Petrov; Yun Hsiao Lin; Chu-Han Feng; Thi Tuyet Mai Nguyen; Jacky Tung; Philippe M Campeau; Uta Behrends; Theresa Brunet; Gloria Sarah Leszinski; Philippe Gros; David Langlais; Anastasia Nijnik
Journal:  JCI Insight       Date:  2020-07-09

3.  TGFβ signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman-Diamond Syndrome.

Authors:  Cailin E Joyce; Assieh Saadatpour; Melisa Ruiz-Gutierrez; Ozge Vargel Bolukbasi; Lan Jiang; Dolly D Thomas; Sarah Young; Inga Hofmann; Colin A Sieff; Kasiani C Myers; Jennifer Whangbo; Towia A Libermann; Chad Nusbaum; Guo-Cheng Yuan; Akiko Shimamura; Carl D Novina
Journal:  J Clin Invest       Date:  2019-06-18       Impact factor: 14.808

Review 4.  [Shwachman-Diamond syndrome and myelodysplastic syndrome with genetic predisposition to myeloid malignancies: two cases report and literature review].

Authors:  J P Li; X Zhao; K Zhou; L Ye; Y Li; Y Li; G X Peng; L P Jing; L Zhang; F K Zhang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-06-14

Review 5.  Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update.

Authors:  Kasiani C Myers; Stella M Davies; Akiko Shimamura
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-03       Impact factor: 3.722

6.  Shwachman-Diamond syndrome: first molecular diagnosis in a Brazilian child.

Authors:  Cresio Alves; Julia Constança Fernandes; Silvana Sampaio; Raquel de Melo Alves Paiva; Rodrigo Tocantins Calado
Journal:  Rev Bras Hematol Hemoter       Date:  2013

7.  Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L.

Authors:  Dong-Hui Chen; Jennifer E Below; Akiko Shimamura; Sioban B Keel; Mark Matsushita; John Wolff; Youngmee Sul; Emily Bonkowski; Maria Castella; Toshiyasu Taniguchi; Deborah Nickerson; Thalia Papayannopoulou; Thomas D Bird; Wendy H Raskind
Journal:  Am J Hum Genet       Date:  2016-06-02       Impact factor: 11.025

8.  A novel mouse model provides insights into the neutropenia associated with the ribosomopathy Shwachman-Diamond syndrome.

Authors:  Kim De Keersmaecker
Journal:  Haematologica       Date:  2015-10       Impact factor: 9.941

9.  Repolarization of HSC attenuates HSCs failure in Shwachman-Diamond syndrome.

Authors:  Hartmut Geiger; Kasiani C Myers; Sachin Kumar; Kalpana J Nattamai; Aishlin Hassan; Amanda Amoah; Rebekah Karns; Cuiping Zhang; Ying Liang; Akiko Shimamura; M Carolina Florian; Ute Bissels; Martha Luevano; Andreas Bosio; Stella M Davies; Medhanie Mulaw
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

Review 10.  Spectrum and risk of neoplasia in Werner syndrome: a systematic review.

Authors:  Julia M Lauper; Alison Krause; Thomas L Vaughan; Raymond J Monnat
Journal:  PLoS One       Date:  2013-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.